EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. GILD

Equity Profile

GILD

Gilead Sciences, Inc.

Health CareBiotechnology$182.4B market cap

Earnings scorecard

Last 75Q

EPS beat streak

10Q

EPS beat rate

79%

Avg EPS surprise

+7.31%

Avg 1-day reaction

+0.27%

Earnings history

76 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingOct 29, 2026————Preview
Q2-2026Aug 4, 2026$-7.07$-6.75+4.58%+3.13%Preview
Q1-2026May 7, 2026$1.91$2.03+7.69%-1.64%Preview
Q4-2025Feb 10, 2026$1.82$1.86+1.92%-2.93%Preview
Q3-2025Oct 30, 2025$2.15$2.47+14.62%-0.05%Preview
Q2-2025Aug 7, 2025ProPreview
Q1-2025Apr 24, 2025ProPreview
Q4-2024Feb 11, 2025ProPreview
Q3-2024Nov 6, 2024ProPreview
Q2-2024Aug 8, 2024ProPreview
Q1-2024Apr 25, 2024ProPreview
Q4-2023Feb 6, 2024ProPreview
Q3-2023Nov 7, 2023ProPreview
Q2-2023Aug 3, 2023ProPreview
Q1-2023Apr 27, 2023ProPreview
Q4-2022Feb 2, 2023ProPreview
Q3-2022Oct 27, 2022ProPreview
Q2-2022Aug 2, 2022ProPreview
Q1-2022Apr 28, 2022ProPreview
Q4-2021Feb 1, 2022ProPreview
Q3-2021Oct 28, 2021ProPreview
Q2-2021Jul 29, 2021ProPreview
Q1-2021Apr 29, 2021ProPreview
Q4-2020Feb 4, 2021ProPreview
Q3-2020Oct 28, 2020ProPreview
Q2-2020Jul 30, 2020ProPreview
Q1-2020Apr 30, 2020ProPreview
Q4-2019Feb 4, 2020ProPreview
Q3-2019Oct 24, 2019ProPreview
Q2-2019Jul 30, 2019ProPreview
Q1-2019May 2, 2019ProPreview
Q4-2018Feb 4, 2019ProPreview
Q3-2018Oct 25, 2018ProPreview
Q2-2018Jul 25, 2018ProPreview
Q1-2018May 1, 2018ProPreview
Q4-2017Feb 6, 2018ProPreview
Q3-2017Oct 26, 2017ProPreview
Q2-2017Jul 26, 2017ProPreview
Q1-2017May 2, 2017ProPreview
Q4-2016Feb 7, 2017ProPreview
Q3-2016Nov 1, 2016ProPreview
Q2-2016Jul 25, 2016ProPreview
Q1-2016Apr 28, 2016ProPreview
Q4-2015Feb 2, 2016ProPreview
Q3-2015Oct 27, 2015ProPreview
Q2-2015Jul 28, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 3, 2015ProPreview
Q3-2014Oct 28, 2014ProPreview
Q2-2014Jul 23, 2014ProPreview
Q1-2014Apr 22, 2014ProPreview
Q4-2013Feb 4, 2014ProPreview
Q3-2013Oct 29, 2013ProPreview
Q2-2013Jul 25, 2013ProPreview
Q1-2013May 2, 2013ProPreview
Q4-2012Feb 4, 2013ProPreview
Q3-2012Oct 23, 2012ProPreview
Q2-2012Jul 26, 2012ProPreview
Q1-2012Apr 26, 2012ProPreview
Q4-2011Feb 2, 2012ProPreview
Q3-2011Oct 27, 2011ProPreview
Q2-2011Jul 26, 2011ProPreview
Q1-2011Apr 20, 2011ProPreview
Q4-2010Jan 25, 2011ProPreview
Q3-2010Oct 19, 2010ProPreview
Q2-2010Jul 20, 2010ProPreview
Q1-2010Apr 20, 2010ProPreview
Q4-2009Jan 26, 2010ProPreview
Q3-2009Oct 20, 2009ProPreview
Q2-2009Jul 21, 2009ProPreview
Q1-2009Apr 21, 2009ProPreview
Q4-2008Jan 27, 2009ProPreview
Q3-2008Oct 16, 2008ProPreview
Q2-2008Jul 17, 2008ProPreview
Q1-2008Apr 16, 2008ProPreview
Q4-2007Jan 23, 2008ProPreview

Next report

Q3-2026

Thu, Oct 29

After the close

Est. EPS

—

Est. Rev

—

Read the preview

About GILD

Sector
Health Care
Industry
Biotechnology
Market cap
$182.4B

71 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Aug 7, 2025ProPreview
Q1-2025Apr 24, 2025ProPreview
Q4-2024Feb 11, 2025Pro
Preview
Q3-2024Nov 6, 2024ProPreview
Q2-2024Aug 8, 2024ProPreview
Q1-2024Apr 25, 2024ProPreview
Q4-2023Feb 6, 2024ProPreview
Q3-2023Nov 7, 2023ProPreview
Q2-2023Aug 3, 2023ProPreview
Q1-2023Apr 27, 2023ProPreview
Q4-2022Feb 2, 2023ProPreview
Q3-2022Oct 27, 2022ProPreview
Q2-2022Aug 2, 2022ProPreview
Q1-2022Apr 28, 2022ProPreview
Q4-2021Feb 1, 2022ProPreview
Q3-2021Oct 28, 2021ProPreview
Q2-2021Jul 29, 2021ProPreview
Q1-2021Apr 29, 2021ProPreview
Q4-2020Feb 4, 2021ProPreview
Q3-2020Oct 28, 2020ProPreview
Q2-2020Jul 30, 2020ProPreview
Q1-2020Apr 30, 2020ProPreview
Q4-2019Feb 4, 2020ProPreview
Q3-2019Oct 24, 2019ProPreview
Q2-2019Jul 30, 2019ProPreview
Q1-2019May 2, 2019ProPreview
Q4-2018Feb 4, 2019ProPreview
Q3-2018Oct 25, 2018ProPreview
Q2-2018Jul 25, 2018ProPreview
Q1-2018May 1, 2018ProPreview
Q4-2017Feb 6, 2018ProPreview
Q3-2017Oct 26, 2017ProPreview
Q2-2017Jul 26, 2017ProPreview
Q1-2017May 2, 2017ProPreview
Q4-2016Feb 7, 2017ProPreview
Q3-2016Nov 1, 2016ProPreview
Q2-2016Jul 25, 2016ProPreview
Q1-2016Apr 28, 2016ProPreview
Q4-2015Feb 2, 2016ProPreview
Q3-2015Oct 27, 2015ProPreview
Q2-2015Jul 28, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 3, 2015ProPreview
Q3-2014Oct 28, 2014ProPreview
Q2-2014Jul 23, 2014ProPreview
Q1-2014Apr 22, 2014ProPreview
Q4-2013Feb 4, 2014ProPreview
Q3-2013Oct 29, 2013ProPreview
Q2-2013Jul 25, 2013ProPreview
Q1-2013May 2, 2013ProPreview
Q4-2012Feb 4, 2013ProPreview
Q3-2012Oct 23, 2012ProPreview
Q2-2012Jul 26, 2012ProPreview
Q1-2012Apr 26, 2012ProPreview
Q4-2011Feb 2, 2012ProPreview
Q3-2011Oct 27, 2011ProPreview
Q2-2011Jul 26, 2011ProPreview
Q1-2011Apr 20, 2011ProPreview
Q4-2010Jan 25, 2011ProPreview
Q3-2010Oct 19, 2010ProPreview
Q2-2010Jul 20, 2010ProPreview
Q1-2010Apr 20, 2010ProPreview
Q4-2009Jan 26, 2010ProPreview
Q3-2009Oct 20, 2009ProPreview
Q2-2009Jul 21, 2009ProPreview
Q1-2009Apr 21, 2009ProPreview
Q4-2008Jan 27, 2009ProPreview
Q3-2008Oct 16, 2008ProPreview
Q2-2008Jul 17, 2008ProPreview
Q1-2008Apr 16, 2008ProPreview
Q4-2007Jan 23, 2008ProPreview